Nature (2016) 536:815
Grska AM, Kamiska K, Wawrzczak-Bargiea A, Costa G, Morelli M, Przewocki R, Kreiner G, Goembiowska K (2018) Neurochemical and neurotoxic effects of MDMA (ecstasy) and caffeine after chronic combined administration in mice
Hin thng hiu ang pht trin hai dng Liposomal Glutathione vi hm lng 500mg v 1000mg
Other notable adverse effects include injection site reactions, fatigue, and hypoglycemia (particularly in patients taking concomitant insulin or insulin secretagogues)
Relamorelin was responsible for glycemic control worsening in 14.5% of patients in a dose-dependent manner
Post-marketing surveillance and FDA Adverse Event Reporting System (FAERS) data have documented isolated reports of patients experiencing dyspnea while taking GLP-1 medications, but establishing causality remains challenging